As of May 22
| -0.28 / -2.25%|
The 5 analysts offering 12-month price forecasts for Sangamo BioSciences Inc have a median target of 22.00, with a high estimate of 30.00 and a low estimate of 17.00. The median estimate represents a +80.77% increase from the last price of 12.17.
The current consensus among 6 polled investment analysts is to Buy stock in Sangamo BioSciences Inc. This rating has held steady since May, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.